In the Bush administration’s ongoing war on regulation, an insidious tactic has emerged. Weaken the regulatory agencies so badly through funding cuts and political appointments that their ability to properly protect the public from defective and dangerous items becomes seriously compromised. Then use that very incompetence as a lawsuit shield for corporations by claiming that regulatory decisions should not be second-guessed by the courts.
As the New York Times has reported. drug companies may find legal protection from lawsuits as a result of the FDA’s inability to properly regulate pharmaceuticals. Cases brought against Johnson & Johnson for deaths and injuries caused by its birth control patch Ortho Evra are now winding their way through the courts, in civil suits around the country where plaintiffs are seeking damages for injury and deaths attributed to blood clots and other conditions brought about by the excessive amounts of estrogen in the Ortho Evra patch. Meanwhile the Bush administration is taking the position that courts should not second guess the decisions of “the only agency with enough expertise to regulate drug makers.”
By now we are all aware that the Bush administration’s regulatory structure is incapable of protecting the public from tainted food and medicine, dangerous toys, poorly maintained airplanes among many other products and services, but who knew that that very uselessness would prove so, well, useful, in court. Thus, in another middle finger salute to the American public, the administration has changed the focus of regulatory agencies, turning them into protectors of the very companies that have sold harmful and/or deadly products to the public. There’s even a catchy name for this legal strategy, one that fits our current rulers to a tee – pre-emption.